PATENT CLAIM ANALYSIS

Application Number: 16090667
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "275000"]

Abstract:
The present invention relates to novel N-[(Pyrimidinylamino)propanyl]- and N-[(Pyridinylamino)propanyl]arylcarboxamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.

Claim (Index 5):
A method of treating a psychiatric or neurological condition associated with impulse control deficits, the method comprising administering a compound according to  claim 1  or a pharmaceutically acceptable salt thereof, to a patient in need thereof.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 97.0
- Lexical Diversity: 1.26087
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16090325', '16090332', '12600388', '15534200', '13124901']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7575946828903322
- 35 USC 102 Novelty (BERT): 0.4981814089877921
- Combined Prediction Score: 0.7316533555000782
- Mean Citation Score: 216.834006
- Max Citation Score: 278.38632
- Similarity Product: 238.7403174736405

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test